Disclaimer: Not investment advice. Do your own research. For informational purposes only. I reserve the right to change positions after publishing as events change. Position rankings are accurate as of pre-market 3/25/24 when writing was completed. This is the second part of yesterday’s post!
You nailed $celh!
i think glycomimetics has a high chance of success with uproleselan plus chemo in relapsed and refractory aml.... see the attached seeking alpha article... https://seekingalpha.com/article/4679755-glycomimetics-can-become-game-changer-in-blood-cancers